DUOGLOBE is a prospective registry of real-life data collection of patients who are treated with intrajejunal levodopa infusion. This study collected data over 2 years in many centers around the world to look at how people who go on this infusion therapy do with their motor, but most importantly, also non-motor issues, their quality of life. We also collected data on caregivers stress. So, if a patient with Parkinson’s gets treatment, what happens to the caregivers? It’s a mixture of all of those data, which was the final data from which was presented in this meeting here today...
DUOGLOBE is a prospective registry of real-life data collection of patients who are treated with intrajejunal levodopa infusion. This study collected data over 2 years in many centers around the world to look at how people who go on this infusion therapy do with their motor, but most importantly, also non-motor issues, their quality of life. We also collected data on caregivers stress. So, if a patient with Parkinson’s gets treatment, what happens to the caregivers? It’s a mixture of all of those data, which was the final data from which was presented in this meeting here today.
The data shows a sustained and consistent improvement in the motor function, but also non-motor functions, particularly sleep, aspects of sleep, aspects of gastrointestinal symptoms, mood, and pain, all improve and is sustained at 2 years. But not just that, caregiver strain also improves and patient’s quality of life improves. So this real-life data, which is beyond the typical population a clinical trial focuses on, really gives us more evidence of the fantastic efficacy of this treatment.